Stada Arzneimittel AG

Issuers

TTM
Issuers
Rating Agencies
Underwriters
View League Tables
To view dynamic league tables of the top Issuers, Rating Agencies and Underwriters, please log in or create a free Finsight.com account.

New Issue Deal Count

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

Recent New Issue

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
HLTH
PRCD
NDDHC 2020-2 (EUR 200m)Stada Arzneimittel AGEMEA
May 5, 2020
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
LVV665.0003.1Sep-94Tl. TeaolekE2HQ+TqphoU94.00-94.50-5713.50%-54.50000
Tranche Comments
4.5 fg: Redemption: 2020-09-30; Registration: 144Q/Zue X; Comments: BOQ200t qx-zrxr att-xq xt 1.085yq 3.5% Eyr 2024 (Sarrv trxt 9/20 50%/25%/rar). Y2/Y/Y+. Eabv Smgm(Y&U)/UY. VYv Yarn/SHE/QCB/Vytt/VEH/HE/Cxtyra/EB/OYE. Fart 94.00-94.50, HFS Y+50. Yyqt 1% 8/24+571. +JQ.;
Use of Proceeds
Hfjfjkk kdjddjknf dojddnfn

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research